Estimation of Primary Prevention of Gout in Men Through Modification of Obesity and Other Key Lifestyle Factors
- PMID: 33231639
- PMCID: PMC7686865
- DOI: 10.1001/jamanetworkopen.2020.27421
Estimation of Primary Prevention of Gout in Men Through Modification of Obesity and Other Key Lifestyle Factors
Abstract
Importance: The population impact of modifying obesity and other key risk factors for hyperuricemia has been estimated in cross-sectional studies; however, the proportion of incident gout cases (a clinical end point) that could be prevented by modifying such factors has not been evaluated.
Objective: To estimate the proportion of incident gout cases that could be avoided through simultaneous modification of obesity and other key risk factors.
Design, setting, and participants: The Health Professionals Follow-up Study is a US prospective cohort study of 51 529 male health professionals enrolled in 1986 and followed up through questionnaires every 2 years through 2012. Self-reported gout cases were confirmed through June 2015. Clean and complete data used for this analysis were available in June 2016, with statistical analyses performed from July 2016 to July 2019.
Exposures: From data collected in the validated questionnaires, men were categorized to low-risk groups according to combinations of the following 4 factors: normal body mass index (BMI [calculated as weight in kilograms divided by height in meters squared]; <25), no alcohol intake, adherence to Dietary Approaches to Stop Hypertension (DASH)-style diet (highest quintile of DASH diet score), and no diuretic use.
Main outcomes and measures: Population attributable risks (PARs) for incident gout meeting the preliminary American College of Rheumatology survey criteria, overall and stratified by BMI.
Results: We analyzed 44 654 men (mean [SD] age, 54.0 [9.8] years) with no history of gout at baseline. During 26 years of follow-up, 1741 (3.9%) developed incident gout. Among all participants, PAR for the 4 risk factors combined (BMI, diet, alcohol use, and diuretic use) was 77% (95% CI, 56%-88%). Among men with normal weight (BMI <25.0) and overweight (BMI 25.0-29.9), we estimated that more than half of incident gout cases (69% [95% CI, 42%-83%] and 59% [95% CI, 30%-75%], respectively) may have been prevented by the combination of DASH-style diet, no alcohol intake, and no diuretic use. However, among men with obesity (BMI ≥30), PAR was substantially lower and not significant (5% [95% CI, 0%-47%]).
Conclusions and relevance: The findings of this cohort study suggest that addressing excess adiposity and other key modifiable factors has the potential to prevent the majority of incident gout cases among men. Men with obesity may not benefit from other modifications unless weight loss is addressed.
Conflict of interest statement
Similar articles
-
The Dietary Approaches to Stop Hypertension (DASH) diet, Western diet, and risk of gout in men: prospective cohort study.BMJ. 2017 May 9;357:j1794. doi: 10.1136/bmj.j1794. BMJ. 2017. PMID: 28487277 Free PMC article.
-
Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study.Arch Intern Med. 2005 Apr 11;165(7):742-8. doi: 10.1001/archinte.165.7.742. Arch Intern Med. 2005. PMID: 15824292
-
Population Impact Attributable to Modifiable Risk Factors for Hyperuricemia.Arthritis Rheumatol. 2020 Jan;72(1):157-165. doi: 10.1002/art.41067. Epub 2019 Dec 3. Arthritis Rheumatol. 2020. PMID: 31486212 Free PMC article.
-
Obesity, hypertension and diuretic use as risk factors for incident gout: a systematic review and meta-analysis of cohort studies.Arthritis Res Ther. 2018 Jul 5;20(1):136. doi: 10.1186/s13075-018-1612-1. Arthritis Res Ther. 2018. PMID: 29976236 Free PMC article.
-
Epidemiology, risk factors, and lifestyle modifications for gout.Arthritis Res Ther. 2006;8 Suppl 1(Suppl 1):S2. doi: 10.1186/ar1907. Epub 2006 Apr 12. Arthritis Res Ther. 2006. PMID: 16820041 Free PMC article. Review.
Cited by
-
Spatiotemporal Observation of Monosodium Urate Crystals Deposition in Synovial Organoids Using Label-Free Stimulated Raman Scattering.Research (Wash D C). 2024 May 27;7:0373. doi: 10.34133/research.0373. eCollection 2024. Research (Wash D C). 2024. PMID: 38803506 Free PMC article.
-
Characterization of a thermostable uricase derived from Thermoactinospora rubra YIM 77501T and its heat-resistant mechanism.Front Microbiol. 2025 Jun 19;16:1615845. doi: 10.3389/fmicb.2025.1615845. eCollection 2025. Front Microbiol. 2025. PMID: 40611964 Free PMC article.
-
Exploring the Multifaceted Nexus of Uric Acid and Health: A Review of Recent Studies on Diverse Diseases.Biomolecules. 2023 Oct 13;13(10):1519. doi: 10.3390/biom13101519. Biomolecules. 2023. PMID: 37892201 Free PMC article. Review.
-
Epidemiology of gout - Global burden of disease research from 1990 to 2019 and future trend predictions.Ther Adv Endocrinol Metab. 2024 Mar 4;15:20420188241227295. doi: 10.1177/20420188241227295. eCollection 2024. Ther Adv Endocrinol Metab. 2024. PMID: 38439915 Free PMC article.
-
Acute gout attacks during the perioperative period and risk factors of recurrence after orthopedic surgery among untreated gout patients.J Orthop Surg Res. 2023 Jan 23;18(1):61. doi: 10.1186/s13018-023-03536-8. J Orthop Surg Res. 2023. PMID: 36683056 Free PMC article.
References
-
- Khanna D, Fitzgerald JD, Khanna PP, et al. ; American College of Rheumatology . 2012 American College of Rheumatology guidelines for management of gout. part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res (Hoboken). 2012;64(10):1431-1446. doi:10.1002/acr.21772 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous